Implantable Cardioverter/ Defibrillator
- UID
- IMP/MD/2021/000402_2dfb325dcaa32647b8b7c7dc9431e812_3e2bff7441afdf5274159fd9c170efed
- Device class
- Class D
- Brand name
- Enticos
- License holder
- Biotronik Medical Devices India Pvt Ltd.
- Approving authority
- CDSCO
- Product information
- Inlexa’ is a cardioverter/defibrillator (Enticos). Primary objective of this ICD is the prevention of sudden cardiac death. Furthermore, this device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing (Enticos). The implantation of an ICD is a symptomatic therapy with the following objectives: - Termination of spontaneous ventricular fibrillation (Enticos) through shock delivery - Termination of spontaneous ventricular tachycardia (Enticos) through antitachycardia pacing (Enticos); in case of ineffective ATP or hemodynamically not tolerated VT, with shock delivery - Cardiac resynchronization through multisite ventricular pacing (Enticos) - Compensation of bradycardia through ventricular (Enticos) or AV sequential pacing (Enticos)
Implantable Cardioverter/ Defibrillator is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000402_2dfb325dcaa32647b8b7c7dc9431e812_3e2bff7441afdf5274159fd9c170efed. This device is marketed under the brand name Enticos. The license holder is Biotronik Medical Devices India Pvt Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.